Bicocca Open Archive

Logo unimib boa
RE, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.488
EU - Europa 6.331
AS - Asia 2.666
SA - Sud America 68
AF - Africa 37
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 17
Totale 19.633
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.246
IT - Italia 1.927
DE - Germania 1.142
CN - Cina 920
SG - Singapore 755
SE - Svezia 725
IE - Irlanda 572
RU - Federazione Russa 443
UA - Ucraina 324
GB - Regno Unito 314
HK - Hong Kong 295
CA - Canada 231
FI - Finlandia 186
IN - India 164
ID - Indonesia 144
VN - Vietnam 143
DK - Danimarca 112
FR - Francia 111
AT - Austria 108
PL - Polonia 77
BR - Brasile 56
BE - Belgio 54
KR - Corea 51
NL - Olanda 51
IR - Iran 39
TR - Turchia 38
ES - Italia 34
JP - Giappone 32
PT - Portogallo 30
RO - Romania 27
AU - Australia 24
BG - Bulgaria 21
GR - Grecia 18
TW - Taiwan 18
CH - Svizzera 17
CZ - Repubblica Ceca 14
EU - Europa 14
IL - Israele 14
ZA - Sudafrica 12
PK - Pakistan 9
MY - Malesia 8
MX - Messico 7
CL - Cile 6
HU - Ungheria 6
PH - Filippine 6
EG - Egitto 5
IQ - Iraq 5
LT - Lituania 5
MU - Mauritius 5
MA - Marocco 4
UZ - Uzbekistan 4
CI - Costa d'Avorio 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
NO - Norvegia 3
TH - Thailandia 3
YE - Yemen 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
BD - Bangladesh 2
ET - Etiopia 2
JM - Giamaica 2
LB - Libano 2
LU - Lussemburgo 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
PA - Panama 1
PY - Paraguay 1
QA - Qatar 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 19.633
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.788
Woodbridge 866
Milan 750
Frankfurt am Main 685
Fairfield 670
Chandler 632
Singapore 623
Wilmington 564
Houston 556
Dublin 551
Ashburn 500
Dearborn 370
Jacksonville 352
Seattle 311
Santa Clara 295
Hong Kong 276
Cambridge 242
New York 217
Princeton 191
Nanjing 161
Jakarta 140
Shanghai 115
Helsinki 106
Vienna 103
Beijing 86
Kraków 74
Lawrence 72
Toronto 71
Guangzhou 68
San Diego 63
Altamura 62
Dong Ket 62
Lachine 58
Ottawa 57
Nanchang 54
Fremont 52
Brussels 50
Melzo 46
Wayne 43
Rome 40
Boardman 35
Kunming 35
Monza 34
Andover 33
Pune 33
Hangzhou 32
Hebei 30
Shenyang 30
Changsha 27
Chicago 27
Nürnberg 26
Grafing 25
Norwalk 24
Zhengzhou 24
Como 23
Tianjin 23
Dallas 21
Falls Church 21
Plovdiv 21
Jiaxing 20
Jinan 20
Lecco 20
London 20
Munich 20
Carate Brianza 19
Los Angeles 19
Brescia 17
Bergamo 16
Edmonton 16
Florence 16
Lansing 16
Turin 15
Genoa 14
Segrate 14
Washington 14
Mountain View 13
New Delhi 13
São Paulo 13
Taipei 13
Taizhou 13
Huizen 12
Kiev 12
Palermo 12
Sacramento 12
Auburn Hills 11
Bologna 11
Ningbo 11
Redmond 11
San Mateo 11
Verona 11
Ahmedabad 10
Boston 10
Cesena 10
Cinisello Balsamo 10
Copenhagen 10
Hefei 10
Montréal 10
Phoenix 10
Porto 10
Siena 10
Totale 14.101
Salva come PNG Salva come JPEG
Nome #
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 493
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 481
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 386
A new approach for glyco-functionalization of collagen-based biomaterials 383
Differential Exchange of Multifunctional Liposomes Between Glioblastoma Cells and Healthy Astrocytes via Tunneling Nanotubes 381
Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size- and time-dependent manner 375
The clustering of mapoe anti-amyloidogenic peptide on nanoparticle surface does not alter its performance in controlling beta-amyloid aggregation 371
Coupling quaternary ammonium surfactants to the surface of liposomes improves both antibacterial efficacy and host cell biocompatibility 360
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 346
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 331
Phage-displayed peptides targeting specific tissues and organs 326
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 323
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 322
The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro 299
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 289
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 281
Nanomedicine for the treatment of Alzheimer's disease 269
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 259
Multifunctional Liposomes Modulate Purinergic Receptor-Induced Calcium Wave in Cerebral Microvascular Endothelial Cells and Astrocytes: New Insights for Alzheimer’s disease 259
Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes 249
Enhanced brain targeting of engineered solid lipid nanoparticles 247
Oxidative stress boosts the uptake of cerium oxide nanoparticles by changing brain endothelium microvilli pattern 247
TrkA pathway activation induced by amyloid-beta (Abeta) 244
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 244
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 244
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 240
Are the nanoparticles friends or foes when inhaled? 240
The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB 237
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 235
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 230
The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease 229
Tat-1-liposomes to overcome the blood-brain barrier: an in vitro study 227
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 222
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 208
Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 206
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 206
Effect of modified collagen on amyloid beta peptide aggregation 202
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 201
Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model 200
Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice 199
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 198
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 198
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 198
An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy 197
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 194
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 192
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 185
Nanoparticles at the neurovascular unit: In vitro and in vivo studies to assess the blood-brain barrier permeability and function 182
Preparation and characterization of lipid-based nanoparticles binding with high affinity amyloid-beta(1-42) peptide 179
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 177
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 177
Enhanced brain targeting of engineered solid lipid nanoparticles 176
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 173
Reduced levels of ABCA1 transporter are responsible for the cholesterol efflux impairment in β‐amyloid‐induced reactive astrocytes: Potential rescue from biomimetic HDLs 170
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 166
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 164
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 163
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 163
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 162
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 161
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 161
Molecular dynamics simulations of doxorubicin in sphingomyelin-based lipid membranes 159
Nanotechnology for neurodegenerative disorders 158
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 153
Nanotechnology for neurodegenerative disorders 152
Effect of curcumin-associated and lipid ligand functionalised nanoliposomes on aggregation of the Alzheimer's Aβ peptide 149
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 149
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study 145
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 144
Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells actively induced by brain targeted liposomes 143
Applications of Surface Plasmon Resonance (SPR) for the Characterization of Nanoparticles Developed for Biomedical Purposes 141
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 141
Development of a 3D in vitro model mimicking the changes occurring at the blood-brain barrier during Alzheimer’s disease 140
Self-assembled electrical biodetector based on reduced graphene oxide 137
Pulmonary administration of functionalized nanoparticles significantly reduces beta-amyloid in the brain of an Alzheimer’s disease murine model 137
Liposomes functionalized with GT1b ganglioside with high affinity for amyloid beta-peptide 136
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 136
Design and validation of a microfluidic device for blood-brain barrier monitoring and transport studies 134
Liposomes capable of effectively binding the beta-amyloid peptide 132
The interaction of complement system with abeta-binding liposomes: towards engineering of safer vesicles for the management of alzheimer's disease 132
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model 131
The 3.0 cell communication: New insights in the usefulness of tunneling nanotubes for glioblastoma treatment 130
From the lungs to the brain: the fantastic voyage of nanoparticles targeting beta-amyloid 129
Nanoparticles for neuroimaging 126
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 123
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 120
Amyposomes: a new nanomedicine for therapy of Alzheimer disease, waiting for clinical trials 119
Biodegradable SPI-based hydrogel for controlled release of nanomedicines: a potential approach against brain tumors recurrence 113
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 112
Potential nanotherapeutic approach for Alzheimer's disease: in vitro clearance of beta-amyloid across the blood-brain barrier by multifunctional liposomes 111
Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model 110
Nanoparticles modulate the stability of the nuclear structure interfering in the mechanical connection between plasma membrane and nucleus 102
Liposomes containing acid lipids and functionalized with a peptide eliciting an efficient removal of beta-amyloid peptide burden from the brain of animal models (transgenic mice) of Alzheimer disease. 100
Design of nanoparticles for the treatment of brain tumors 99
Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells actively induced by brain targeted liposomes 90
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 78
In Vitro Biocompatibility and Endothelial Permeability of Branched Polyglycidols Generated by Ring-Opening Polymerization of Glycidol with B(C6F5)3 under Dry and Wet Conditions 74
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 73
Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions 68
The fantastic voyage of solid lipid nanoparticles from the lung to the brain: non‐invasive tomographic imaging as a feasible refinement process 65
Totale 19.818
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.847
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.657 0 0 0 0 0 0 503 317 309 232 217 79
2020/20213.055 161 139 306 277 222 277 284 275 278 299 215 322
2021/20222.187 200 204 198 209 148 188 164 136 114 164 181 281
2022/20232.938 359 818 293 295 198 432 57 140 166 33 86 61
2023/20242.332 64 81 132 161 240 542 410 117 134 55 114 282
2024/20252.530 280 461 393 305 456 370 265 0 0 0 0 0
Totale 20.526